Literature DB >> 29654741

RHBDF1 regulates APC-mediated stimulation of the epithelial-to-mesenchymal transition and proliferation of colorectal cancer cells in part via the Wnt/β-catenin signalling pathway.

Huiping Yuan1, Ran Wei2, Yuhong Xiao3, Yi Song1, Jia Wang1, Huihuan Yu1, Ting Fang3, Wei Xu4, Shengxun Mao5.   

Abstract

The human rhomboid family-1 gene (RHBDF1) is an oncogene in breast and head and neck squamous cancers. Here, we show that RHBDF1 plays a significant role in colorectal cancer (CRC) formation and that the RHBDF1 expression level is higher in CRC than in corresponding normal tissues. Moreover, RHBDF1 promotes cell proliferation, invasion and migration in vitro. Furthermore, through overexpression and silencing of RHBDF1 and the mediator complex, our study demonstrates that RHBDF1 may positively regulate adenomatous polyposis coli (APC) in the Wnt/β-catenin signalling pathway to increase the expression levels of MMP-14 and Twist, which act as important epithelial-to-mesenchymal transition (EMT) stimulating factors. Additionally, RHBDF1 may regulate c-myc and CyclinD1 expression to influence cell proliferation. Finally, RHBDF1 overexpression and silencing influence CRC growth in BALB/c nude mice. In summary, our findings demonstrate that the regulatory effects of RHBDF1 on EMT and on cell proliferation are partially attributable to the Wnt/β-catenin signalling pathway.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  APC; Colorectal cancer; EMT; RHBDF1; Wnt/β-catenin

Mesh:

Substances:

Year:  2018        PMID: 29654741     DOI: 10.1016/j.yexcr.2018.04.009

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  7 in total

1.  TGM2 interference regulates the angiogenesis and apoptosis of colorectal cancer via Wnt/β-catenin pathway.

Authors:  Ping Yang; Dong Yu; Jie Zhou; Sufei Zhuang; Tao Jiang
Journal:  Cell Cycle       Date:  2019-05-08       Impact factor: 4.534

2.  Alternative splicing of the human rhomboid family-1 gene RHBDF1 inhibits epidermal growth factor receptor activation.

Authors:  Renpeng Ji; Qianqian Shi; Yixin Cao; Jingyue Zhang; Cancan Zhao; Huanyu Zhao; Yasra Sayyed; Li Fu; Lu-Yuan Li
Journal:  J Biol Chem       Date:  2022-05-18       Impact factor: 5.486

3.  The molecular, cellular and pathophysiological roles of iRhom pseudoproteases.

Authors:  Iqbal Dulloo; Sonia Muliyil; Matthew Freeman
Journal:  Open Biol       Date:  2019-03-29       Impact factor: 6.411

4.  Therapeutic strategies targeting Wnt/β‑catenin signaling for colorectal cancer (Review).

Authors:  Yong Ji; Jian Lv; Di Sun; Yufeng Huang
Journal:  Int J Mol Med       Date:  2021-10-29       Impact factor: 4.101

5.  Network Pharmacology Analysis, Molecular Docking, and In Vitro Verification Reveal the Action Mechanism of Prunella vulgaris L. in Treating Breast Cancer.

Authors:  Haotian Bai; Rui Wang; Yalan Li; Xiao Liang; Junhao Zhang; Na Sun; Jing Yang
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-10       Impact factor: 2.650

6.  Rhomboids and regulation of receptor tyrosine kinase ligands shedding.

Authors:  Niki Karachaliou; Rafael Rosell
Journal:  EBioMedicine       Date:  2018-10-06       Impact factor: 8.143

7.  Association of iRhom1 and iRhom2 expression with prognosis in patients with cervical cancer and possible signaling pathways.

Authors:  Qin Xu; Chuanben Chen; Bin Liu; Yibin Lin; Peng Zheng; Dongmei Zhou; Yunqing Xie; Ya Lin; Ciren Guo; Jing Liu; Li Li
Journal:  Oncol Rep       Date:  2019-10-25       Impact factor: 3.906

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.